| Literature DB >> 29905087 |
David Joshua Cohen1, Sharon L Hyzy1, Salma Haque2, Lucas C Olson1, Barbara D Boyan1,3, Justin M Saul2, Zvi Schwartz1,4.
Abstract
IMPACT STATEMENT: Recombinant human bone morphogenetic protein 2 (rhBMP-2) delivery from collagen sponges for bone formation is an important clinical example of growth factors in tissue engineering. Side effects from rhBMP-2 burst release and rapid collagen resorption have led to investigation of alternative carriers. Here, keratin carriers with tunable erosion rates were formulated by varying disulfide crosslinking via ratios of oxidatively (keratose) to reductively (kerateine) extracted keratin. In vitro rhBMP-2 bioactivity increased with kerateine content, reaching levels greater than with collagen. Heterotopic bone formation in a mouse model depended on the keratin formulation, highlighting the importance of the growth factor carrier.Entities:
Keywords: bone morphogenetic protein 2; collagen; drug delivery; kerateine; keratose; synthetic bone graft
Mesh:
Substances:
Year: 2018 PMID: 29905087 PMCID: PMC6238606 DOI: 10.1089/ten.TEA.2017.0471
Source DB: PubMed Journal: Tissue Eng Part A ISSN: 1937-3341 Impact factor: 3.845